A number of Japanese herbal medicine brands have been making the news this week, with the introduction of some brand new strains.
But it’s not just Japanese brands that are making headlines, and it’s also one of the world’s top herbal medicines, Aristolochium.
The herb is being hailed by doctors, dentists and pharmacists as a treatment for various health problems and is being sold in Japan.
But now it’s coming under fire from the country’s government, who say it’s dangerous to use and should not be sold.
And some Japanese medical groups are urging the government to pull Aristolo’s approval.
The brand is currently undergoing a safety review, which will also include a more rigorous inspection of its potency.
Aristolochios’ main ingredient is a type of algae called A. mellea, which is commonly found in seaweed and seaweed pods.
It contains an alkaline compound, alkaloids, which are powerful painkillers and are considered safe for human use.
A number of other herbs are also available in Japan, including ginseng and black cohosh.
These are the same types of alkaloid, which also causes the painkilling effects, but can also cause severe side effects such as liver and kidney damage.
Japanese Prime Minister Shinzo Abe says his government is “extremely cautious” about the use of Aristolocochia in Japan and has warned against the “disease-causing properties”.
Aristols herbal medicine is currently available in three brands.
One is called “Aristolyte” which is sold in shops across Japan.
It has a range of claims, including reducing inflammation, reducing blood pressure, easing pain, relieving muscle pain and treating insomnia.
The other two brands are called “Ginny’s”, which is marketed under the name “Ginseng” and is made by the Japanese brand Ginjin.
The herbal medicine has been tested in a number of studies and is claimed to reduce inflammation, reduce blood pressure and reduce muscle pain.
It has also been tested against some rare and life-threatening conditions, such as leukaemia and cancer.
Ginsenosan is a generic version of Aristo, and is a brand which has been available in the US for some time.
It is currently being marketed under a brand name called “Ranbu”.
Its ingredient is called arbutin, which causes the body to produce an enzyme called arginase, which converts the sugar in the blood into arginine, which in turn is used as a neurotransmitter and a painkiller.
Its active ingredient is linalool, which acts as an anti-inflammatory.
The American version of the product is called Ranbu.
Ginjin also sells a range to treat conditions such as arthritis and depression, and also has a “natural” version of Ginjin called Ranbo.
It sells for around ¥1,500, which has not changed in the last 10 years, although the price has risen from ¥100 in 2008 to ¥3,000 today.
The Japanese government says Ranbu is safe for people of all ages and can treat depression, arthritis and other conditions.
It also states Ranbu will not be used as treatment for conditions that cause pain and inflammation.
A few weeks ago, the Japanese government banned the sale of Ginjins herbal medicine products, citing concerns about its side effects.
The government said that the drug, which was first developed in the 1970s, is an herbal medicine that does not contain the active ingredient, arbutins main ingredient.
It’s claimed that Ginjin is safe and effective for treating depression and other disorders.
But in a statement released by the Health Ministry on Monday, it warned against its use in people with cancer and arthritis, saying it could cause serious side effects, such a heart attack, stroke or even death.
“These medicines are not approved for use by patients under the age of 18,” it said.
“The use of these products by persons over the age in their 20s and 30s could cause severe damage to the heart, blood vessels, and nervous system.”
The ministry said the sale and import of Ginju will be banned.